Search Results - "Patberg, Kornelis Wiebe"

Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma – First Initiators and Switchers by Hashimoto, Simone, Kroes, Johannes A., Eger, Katrien A., Mau Asam, Pearl F., Hofstee, Hendrik B., Bendien, Sarah A., Braunstahl, Gert Jan, Broeders, Marielle E.A.C., Imming, Leonie M., Langeveld, Bas, Maitland-van der Zee, Anke H., Oud, Karen T.M., Patberg, Kornelis Wiebe, Smeenk, Frank W.J.M., Romme, Elisabeth A.P.M., van Bezouw, Maarten J., van de Ven, Marjo J., van Veen, Anneke, van Velzen, Edwin, van Veen, Ilonka H.P.A.A., Weersink, Els J.M., Ten Brinke, Anneke, Sont, Jacob K., Bel, Elisabeth H.

“…Reslizumab, a biologic targeting IL-5, has been shown to reduce asthma exacerbations and maintenance oral corticosteroid use in randomized controlled trials…”
Get full text

Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis by Bendien, Sarah A., Kroes, Johannes A., van Hal, Lotte H.G., Braunstahl, Gert-Jan, Broeders, Marielle E.A.C., Oud, Karen T.M., Patberg, Kornelis Wiebe, Smeenk, Frank W.J.M., van Veen, Ilonka H.P.A.A., Weersink, Els J.M., Fieten, Karin B., Hashimoto, Simone, van Veen, Anneke, Sont, Jaap K., van Huisstede, Astrid, van de Ven, Marjo J.T., Langeveld, Bas, Maitland-van der Zee, Anke-Hilse, ten Brinke, Anneke

“…Bronchiectasis is a common comorbidity in patients with asthma and is associated with increased disease severity. In patients with severe eosinophilic asthma,…”
Get full text